Table 2 Summary of correlation between FAM83H-AS1 expression and clinicopathological characteristics of cancers
From: The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis
Clinicopathological parameters | Studies | Patients | OR (95% CI) | P-value | Heterogeneity | ||
|---|---|---|---|---|---|---|---|
I2 (%) | P-value | Model | |||||
Age (older vs. younger) | 10 | 847 | 0.83 (0.63, 1.09) | 0.19 | 0 | 0.44 | Fixed |
Gender (male vs. female) | 8 | 666 | 0.92 (0.67, 1.27) | 0.62 | 10 | 0.35 | Fixed |
Tumor size (larger vs. smaller) | 10 | 840 | 1.20 (0.55, 2.64) | 0.65 | 85 | 0.0001 | Random |
Differentiation (poor vs. well) | 8 | 630 | 1.19 (0.60, 2.37) | 0.62 | 72 | 0.0007 | Random |
TNM stage (III + IV vs. I + II) | 9 | 678 | 2.40 (1.36, 4.23) | 0.003 | 62 | 0.007 | Random |
LNM (positive vs. negative) | 6 | 560 | 1.70 (1.14, 2.52) | 0.008 | 15 | 0.32 | Fixed |
DM (positive vs. negative) | 5 | 442 | 2.23 (0.65, 7.67) | 0.20 | 70 | 0.01 | Random |